scholarly article | Q13442814 |
P50 | author | Robert A Rissman | Q88618697 |
P2093 | author name string | Kenner C Rice | |
Cheng Zhang | |||
Louise Monte | |||
Ching-Chang Kuo | |||
Setareh H Moghadam | |||
P2860 | cites work | Neuropeptide abnormalities in patients with early Alzheimer disease | Q73191849 |
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease | Q21144713 | ||
Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 | ||
S-glutathionylation: from molecular mechanisms to health outcomes | Q30398587 | ||
Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis | Q33607471 | ||
Oxidative stress in the progression of Alzheimer disease in the frontal cortex | Q33680790 | ||
Adverse stress, hippocampal networks, and Alzheimer's disease | Q33708011 | ||
Oxidative stress and Alzheimer disease | Q33841850 | ||
S-Glutathionyl quantification in the attomole range using glutaredoxin-3-catalyzed cysteine derivatization and capillary gel electrophoresis with laser-induced fluorescence detection | Q33993016 | ||
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration | Q34071097 | ||
The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. | Q34182381 | ||
Glutathione peroxidase enzyme activity in aging | Q34240689 | ||
Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease | Q34459616 | ||
Localizing movement-related primary sensorimotor cortices with multi-band EEG frequency changes and functional MRI | Q34465996 | ||
Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis | Q34466540 | ||
Principal component analysis reveals age-related and muscle-type-related differences in protein carbonyl profiles of muscle mitochondria | Q34570379 | ||
Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor | Q34644508 | ||
Detection and quantification of 8-hydroxy-2'-deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis. | Q34742674 | ||
Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model | Q35007956 | ||
Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias. | Q35023154 | ||
Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease | Q35458379 | ||
Cellular Redox: A Modulator of Intestinal Epithelial Cell Proliferation | Q35538744 | ||
Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation | Q35924838 | ||
Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis | Q36057680 | ||
The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. | Q36399313 | ||
Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy | Q36399799 | ||
Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? | Q36499640 | ||
Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. | Q36841921 | ||
Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease | Q36984455 | ||
Causes and consequences of cysteine S-glutathionylation | Q37168359 | ||
CRF system recruitment mediates dark side of compulsive eating | Q37446510 | ||
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism | Q37603401 | ||
Role of the p53 Family in Stabilizing the Genome and Preventing Polyploidization | Q37778010 | ||
Elevation of glutathione as a therapeutic strategy in Alzheimer disease | Q37947939 | ||
Oxidative stress and the ageing endocrine system | Q38084435 | ||
Effect of protein glutathionylation on neuronal cytoskeleton: a potential link to neurodegeneration | Q39518027 | ||
Glutathione peroxidase activity is neuroprotective in models of Huntington's disease | Q40129680 | ||
Oxidative stress hypothesis in Alzheimer's disease | Q41482152 | ||
Long-Term Electrophysiological and Behavioral Analysis on the Improvement of Visual Working Memory Load, Training Gains, and Transfer Benefits | Q41778000 | ||
Elevation by oxidative stress and aging of hypothalamic-pituitary-adrenal activity in rats and its prevention by vitamin e | Q42115631 | ||
Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin | Q42465882 | ||
Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment | Q42963006 | ||
The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress | Q44285597 | ||
Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. | Q44934002 | ||
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists | Q45039920 | ||
Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent. | Q45924774 | ||
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse | Q46125569 | ||
Proneness to psychological distress is associated with risk of Alzheimer's disease | Q47333653 | ||
Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease | Q48398841 | ||
Two-dimensional nitrosylated protein fingerprinting by using poly (methyl methacrylate) microchips | Q48450021 | ||
Distress proneness and cognitive decline in a population of older persons. | Q50748610 | ||
Impaired glutathione peroxidase activity accounts for the age-related accumulation of hydrogen peroxide in activated human neutrophils. | Q52243066 | ||
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. | Q53193396 | ||
P433 | issue | 2 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 639-650 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
P1476 | title | Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model | |
P478 | volume | 45 |
Q38657509 | Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice. |
Q60313606 | Motor and Nonmotor Symptoms of Parkinson’s Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability? |
Q55177547 | The relationship between stress and Alzheimer's disease. |
Search more.